Clinical pharmacists, physicians, nurses, and other practitioners who work with pediatric patients have a new resource: the second edition of Pediatric Pharmacotherapy. This important textbook, originally published in 2013, has been updated in several ways:
- New chapters have been added on acute kidney injury, oncologic emergencies, and adrenal insufficiency to provide readers with information to positively affect their care for patients with these conditions
- Patient-specific cases have been added to each disease-specific chapter, developed to help readers apply the information. Cases highlight common pediatric disorders or diseases that may be encountered in clinical care in an ambulatory, community, or acute setting.
- All chapters have been updated with the latest information regarding specific disease states, drug selection and use, monitoring of effectiveness and toxicity, prevention of medication errors, and patient/caregiver education.
Editors Sandra Benavides, Pharm.D., FCCP, FPPA, and Milap C. Nahata, Pharm.D., M.S., FCCP, FAPhA, FASHP, FPPA, together with dozens of expert authors and reviewers, have updated the book while staying true to its vision – helping readers learn about the characteristics that distinguish the pediatric population from the adult population. As they say in the preface to the new edition,
The uniqueness of neonates, infants, children, and adolescents goes beyond the physical and developmental distinctions. Consequently, drugs behave differently in this population. Medications may not be absorbed, distributed, metabolized, or eliminated the same as in adults, and the pharmacokinetics of medications may vary across the age continuum from birth to adolescence.
In addition, they add, children can be affected by unique health conditions that are not yet fully understood.
This new edition of Pediatric Pharmacotherapy equips practitioners with the information they need to optimize outcomes in this patient population. The book is available in print and eBook formats in the ACCP Bookstore.